Literature DB >> 24930617

Residual and recurrent gradients after septal myectomy for hypertrophic cardiomyopathy-mechanisms of obstruction and outcomes of reoperation.

Yang Hyun Cho1, Eduard Quintana2, Hartzell V Schaff3, Rick A Nishimura4, Joseph A Dearani5, Martin D Abel6, Steve Ommen4.   

Abstract

OBJECTIVE: The aims of the present study were to identify the mechanisms of residual or recurrent left ventricular outflow tract obstruction in patients undergoing repeat septal myectomy for hypertrophic cardiomyopathy and to assess the early and late results of reoperation.
METHODS: From January 1980 to June 2012, we performed 52 repeat myectomies in 51 patients. We reviewed the medical records and preoperative transthoracic echocardiograms to evaluate the adequacy of the previous resection and mechanism of left ventricular outflow tract obstruction. The complications of previous and repeat myectomy, New York Heart Association class, and survival were analyzed.
RESULTS: The mean interval from previous myectomy to reoperation was 43 ± 51 months. In 6 patients (12%) residual or recurrent gradients were caused by isolated midventricular obstruction. In the remaining 46 operations, the mechanism of residual or recurrent gradients was identified as systolic anterior motion of mitral valve-related subaortic obstruction caused by inadequate length of previous subaortic septal excision in 31 patients (59% of the total), both an inadequate length and an inadequate depth of septectomy in 13 patients (25%), and both residual subaortic obstruction due to systolic anterior motion of the mitral valve and midventricular obstruction in 2 patients (4%). Preoperatively, 96% of patients were in New York Heart Association class III or IV; postoperatively, 93.8% were in class I or II (P < .001). The 10-year survival after reoperation was 98% and similar to that of an age- and gender-matched Minnesota population (P = .46).
CONCLUSIONS: The most common cause of recurrent left ventricular outflow tract obstruction and symptoms in patients undergoing septal myectomy has been an inadequate length of septal excision. Reoperation is safe, with excellent long-term survival and functional improvement.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24930617     DOI: 10.1016/j.jtcvs.2014.05.028

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  11 in total

Review 1.  Management of the mitral valve in patients with obstructive hypertrophic cardiomyopathy.

Authors:  Joon Hwa Hong; Anita Nguyen; Hartzell Vernon Schaff
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-05-07

2.  Isolated septal myectomy for hypertrophic obstructive cardiomyopathy: an update on the Toronto General Hospital experience.

Authors:  Rachel D Vanderlaan; Anna Woo; Anthony Ralph-Edwards
Journal:  Ann Cardiothorac Surg       Date:  2017-07

Review 3.  Surgical treatment for hypertrophic cardiomyopathy: a historical perspective.

Authors:  Dustin Hang; Anita Nguyen; Hartzell V Schaff
Journal:  Ann Cardiothorac Surg       Date:  2017-07

4.  Application of cryoenergy to improve septal exposure during transaortic septal myectomy in hypertrophic obstructive cardiomyopathy.

Authors:  Alberto Pozzoli; Luca Vicentini; Stefan Thelin; Elisabetta Lapenna; Leif Nilsson; Ottavio Alfieri
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-08-20

Review 5.  Surgical management of left ventricular outflow obstruction in hypertrophic cardiomyopathy.

Authors:  Neil Howell; William Bradlow
Journal:  Echo Res Pract       Date:  2015-03-09

6.  Extended myectomy in the treatment of patients with hypertrophic obstructive cardiomyopathy.

Authors:  Mateusz Kuć; Piotr Kołsut; Jacek Różański; Maciej Dąbrowski; Mariusz Kłopotowski; Magda Kumor; Mirosław Kowalski; Natalia Kopyłowska; Jarosław Kuriata; Mariusz Kuśmierczyk
Journal:  Kardiochir Torakochirurgia Pol       Date:  2016-12-30

7.  Early results of optimal septal myectomy using 3-dimensional printed models.

Authors:  Uladzimir Andrushchuk; Vitali Adzintsou; Artsem Niavyhlas; Hanna Model; Youry Ostrovsky
Journal:  Kardiochir Torakochirurgia Pol       Date:  2019-06-28

8.  Anterior mitral leaflet length and mitral annulus diameter impact the echocardiographic outcome after isolated myectomy.

Authors:  Mateusz Kuć; Magdalena Kumor; Mariusz Kłopotowski; Maciej Dąbrowski; Natalia Kopyłowska-Kuć; Piotr Kołsut; Mariusz Kuśmierczyk
Journal:  J Cardiothorac Surg       Date:  2019-12-05       Impact factor: 1.637

9.  Mini-invasive surgical instruments in transaortic myectomy for hypertrophic obstructive cardiomyopathy: a single-center experience with 168 cases.

Authors:  Qiang Ji; Yu Lin Wang; Ye Yang; Hao Lai; Wen Jun Ding; Li Min Xia; Chun Sheng Wang
Journal:  J Cardiothorac Surg       Date:  2021-03-17       Impact factor: 1.637

10.  Long-term clinical and echocardiographic outcomes of extensive septal myectomy for hypertrophic obstructive cardiomyopathy in Chinese patients.

Authors:  Lei Yao; Li Li; Xiong-Jun Lu; Yan-Ling Miao; Xiao-Ning Kang; Fu-Jian Duan
Journal:  Cardiovasc Ultrasound       Date:  2016-05-17       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.